Forwarded from CapelloBiancoQ
Media is too big
VIEW IN TELEGRAM
Nanotechnologie in mRNA-Corona-Spritzen? - Dr. Ute Krüger
⚪️ CapelloBiancoQ
https://t.me/CapelloBiancoQ
Rabatte und Empfehlungen
https://t.me/ViamEmpfehlungen
⚪️ CapelloBiancoQ
https://t.me/CapelloBiancoQ
Rabatte und Empfehlungen
https://t.me/ViamEmpfehlungen
https://x.com/aprilww911lc/status/2089481153518637448
Gott vergib ihnen, denn sie wussten nicht was sie taten...
Gott vergib ihnen, denn sie wussten nicht was sie taten...
Forwarded from Uncut-News.ch "Das Original"🇨🇭Unabhängige Analysen und Informationen zu Geopolitik, Wirtschaft, Gesundheit, Technologie
Dowd: Zahl der Menschen mit Behinderung in den USA erreicht im Juli mit 37 Millionen einen neuen Höchststand: Anstieg um 23 % seit Februar 2021
Von Tyler Durden
Verfasst von Ed Dowd via Beyond The Narrative,
Die neuesten Daten des Bureau of Labor Statistics liegen vor, und die Zahl der Amerikaner ab 16 Jahren, die eine…
https://uncutnews.ch/dowd-zahl-der-menschen-mit-behinderung-in-den-usa-erreicht-im-juli-mit-37-millionen-einen-neuen-hoechststand-anstieg-um-23-seit-februar-2021/
🔴 Nichts verpassen 📬⚡️Abo → @uncut_news
🔴 Spenden: https://uncutnews.ch/kontakt/ DANKE ❤️
*
Von Tyler Durden
Verfasst von Ed Dowd via Beyond The Narrative,
Die neuesten Daten des Bureau of Labor Statistics liegen vor, und die Zahl der Amerikaner ab 16 Jahren, die eine…
https://uncutnews.ch/dowd-zahl-der-menschen-mit-behinderung-in-den-usa-erreicht-im-juli-mit-37-millionen-einen-neuen-hoechststand-anstieg-um-23-seit-februar-2021/
🔴 Nichts verpassen 📬⚡️Abo → @uncut_news
🔴 Spenden: https://uncutnews.ch/kontakt/ DANKE ❤️
*
👀1
High-Profile Departures Shake Up WHO Leadership, ‘Controversial’ Appointee Returns
https://healthpolicy-watch.news/high-profile-departures-who-leadership/
Top British scientist steps down from WHO
Exclusive: Sir Jeremy Farrar, who advised the government on Covid, resigns after helping to implement job cuts at global body
https://www.telegraph.co.uk/global-health/science-and-disease/top-uk-scientist-steps-down-from-who/
https://healthpolicy-watch.news/high-profile-departures-who-leadership/
Top British scientist steps down from WHO
Exclusive: Sir Jeremy Farrar, who advised the government on Covid, resigns after helping to implement job cuts at global body
https://www.telegraph.co.uk/global-health/science-and-disease/top-uk-scientist-steps-down-from-who/
Health Policy Watch
High-Profile Departures Shake Up WHO Leadership, 'Controversial' Appointee Returns - Health Policy Watch
A major shake-up is rocking WHO leadership, with two assistant directors-general leaving the organisation in quick succession. Dr Bruce Aylward succeeds Dr Jeremy Farrar, while Dr Sylvie Briand will serve as acting head to replace Dr Yukiko Nakatani. Moreover…
Erstes Substack von Rantanplan.
😊
Anderes Thema, trotzdem interessant.
https://rantanplan2.substack.com/p/ein-stilles-verbrechen-an-der-landschaft?r=6ogofm&utm_campaign=post-expanded-share&utm_medium=web
😊
Anderes Thema, trotzdem interessant.
https://rantanplan2.substack.com/p/ein-stilles-verbrechen-an-der-landschaft?r=6ogofm&utm_campaign=post-expanded-share&utm_medium=web
Substack
Ein stilles Verbrechen an der Landschaft
Was ein geöffnetes Wehr bei Oferdingen, verschwundener Baumbestand in Wannweil und die Antworten der Behörden miteinander zu tun haben
👍5😡1
Forwarded from henning rosenbusch - Channel
This media is not supported in your browser
VIEW IN TELEGRAM
In Italien weiß niemand was von Hitzetoten oder Übersterblichkeit.
Muss eine andere Hitze-Variante sein oder es hat noch niemand Bescheid gesagt.
In Rom ist es im Juli/August übrigens durchschnittlich 7 Grad wärmer als in Deutschland.
https://www.deutschlandfunk.de/viel-zustimmung-fuer-hitzeschutz-vorschlaege-der-spd-union-weiterhin-skeptisch-102.html
t.me/Rosenbusch
Muss eine andere Hitze-Variante sein oder es hat noch niemand Bescheid gesagt.
In Rom ist es im Juli/August übrigens durchschnittlich 7 Grad wärmer als in Deutschland.
https://www.deutschlandfunk.de/viel-zustimmung-fuer-hitzeschutz-vorschlaege-der-spd-union-weiterhin-skeptisch-102.html
t.me/Rosenbusch
🔥1
Forwarded from Dr. Lynn Fynn’s Science Enlightenment Channel & Stuff
27 injections for $500,000 and zero long term evidence of benefit-
Moderna Melanoma “vaccine”.
Moderna Melanoma “vaccine”.
Dr. Lynn Fynn’s Science Enlightenment Channel & Stuff
27 injections for $500,000 and zero long term evidence of benefit- Moderna Melanoma “vaccine”.
Korrektur
(Danke Klaus)
Das stimmt so nicht: Es sind wohl 9 mRNA-Injektionen für das gesamte Protokoll. Dazu kommen 18 Dosen Pembrolizumab. In neueren Protokollen wohl auch nur noch 9x Pembrolizumab. Der Preis soll auch noch nicht feststehen.
https://www.merck.com/news/mrna-4157-v940-an-investigational-personalized-mrna-cancer-vaccine-in-combination-with-keytruda-pembrolizumab-receives-prime-scheme-designation-from-the-european-medicines-agency-for-adjuva/
(Danke Klaus)
Das stimmt so nicht: Es sind wohl 9 mRNA-Injektionen für das gesamte Protokoll. Dazu kommen 18 Dosen Pembrolizumab. In neueren Protokollen wohl auch nur noch 9x Pembrolizumab. Der Preis soll auch noch nicht feststehen.
https://www.merck.com/news/mrna-4157-v940-an-investigational-personalized-mrna-cancer-vaccine-in-combination-with-keytruda-pembrolizumab-receives-prime-scheme-designation-from-the-european-medicines-agency-for-adjuva/
Merck.com
mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination with KEYTRUDA® (pembrolizumab), Receives PRIME…
Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial and unmet need for additional therapeutic options for certain types of melanoma CAMBRIDGE, MA and RAHWAY, N.J., April 6, 2023 – Moderna, Inc. (NASDAQ:MRNA), a biotechnology…
Two-dimensional AEX – IP-RPLC: New insights on mRNA integrity and encapsulation efficiency of mRNA-lipid nanoparticle formulations
"Encapsulation efficiency (EE) and mRNA integrity are particularly critical, yet current analytical approaches often require separate assays, challenging sample handling, and limited selectivity toward free versus encapsulated species. Therefore, new chromatographic methods capable of resolving these species and supporting multi-payload formulations remain a major unmet need."
"The most widely used strategy to determine EE is a fluorescence-based assay usually employing the RiboGreen dye. Although this method is widely used, it has limitations. First, the use of the manual protocol is labor-intensive, and it often involves significant dilutions of the samples that can alter the structure of some LNPs. Secondly, because it relies on mRNA-dye biding, it is highly sensitive to matrix effects such as pH, ionic strength, buffer composition, and dilution [3,4]. As a novel alternative, Maurer et al. utilized hydrophilic interaction chromatography (HILIC) to measure EE under two mobile phase conditions: intact separation and online LNP disruption [5]. However, they noted robustness issues and pore-size mismatches in HILIC relative to the hydrodynamic radii of large mRNA species. Gao et al. proposed using asymmetrical flow field-flow fractionation (AF4) to measure encapsulation efficiency in a single injection [6]. AF4 separates molecules by hydrodynamic size using crossflow in a thin channel. However, implementation can be challenging due to recovery issues and complex instrumentation. Analytical ultracentrifugation has also shown promising results, opening new avenues for EE determinations [7]. Finally, ion exchange chromatography has been proposed, separating LNPs and mRNA based on charge differences [8,9]. This technique was shown to provide robust and reproducible measurements and mitigated specificity issues. In their study, Tsalmpouris et al. emphasized that AEX could give information on the localization of mRNA on the surface of LNPs, improving the understanding of mRNA-LNP formulation [9]."
https://www.sciencedirect.com/science/article/pii/S0003267026001650
"Encapsulation efficiency (EE) and mRNA integrity are particularly critical, yet current analytical approaches often require separate assays, challenging sample handling, and limited selectivity toward free versus encapsulated species. Therefore, new chromatographic methods capable of resolving these species and supporting multi-payload formulations remain a major unmet need."
"The most widely used strategy to determine EE is a fluorescence-based assay usually employing the RiboGreen dye. Although this method is widely used, it has limitations. First, the use of the manual protocol is labor-intensive, and it often involves significant dilutions of the samples that can alter the structure of some LNPs. Secondly, because it relies on mRNA-dye biding, it is highly sensitive to matrix effects such as pH, ionic strength, buffer composition, and dilution [3,4]. As a novel alternative, Maurer et al. utilized hydrophilic interaction chromatography (HILIC) to measure EE under two mobile phase conditions: intact separation and online LNP disruption [5]. However, they noted robustness issues and pore-size mismatches in HILIC relative to the hydrodynamic radii of large mRNA species. Gao et al. proposed using asymmetrical flow field-flow fractionation (AF4) to measure encapsulation efficiency in a single injection [6]. AF4 separates molecules by hydrodynamic size using crossflow in a thin channel. However, implementation can be challenging due to recovery issues and complex instrumentation. Analytical ultracentrifugation has also shown promising results, opening new avenues for EE determinations [7]. Finally, ion exchange chromatography has been proposed, separating LNPs and mRNA based on charge differences [8,9]. This technique was shown to provide robust and reproducible measurements and mitigated specificity issues. In their study, Tsalmpouris et al. emphasized that AEX could give information on the localization of mRNA on the surface of LNPs, improving the understanding of mRNA-LNP formulation [9]."
https://www.sciencedirect.com/science/article/pii/S0003267026001650
❤1
"Finally, we also showed the side effects of dysfunctional BM niche macrophages on hematopoiesis in mice, such as the promotion of myeloid-biased output and impairment of erythropoiesis. This study not only draws attention to the safety of liposomal drugs in clinical practice but also provides new directions for the design of lipid-based drug carriers in preclinical studies."
https://www.jlr.org/article/S0022-2275(22)00106-7/fulltext
https://www.jlr.org/article/S0022-2275(22)00106-7/fulltext
Journal of Lipid Research
Liposomes trigger bone marrow niche macrophage “foam” cell formation and affect hematopoiesis in mice
Liposomes are the most widely used nanocarrier platform for the delivery of therapeutic
and diagnostic agents, and a number of liposomes have been approved for use in clinical
practice. After systemic administration, most liposomes are cleared by macrophages…
and diagnostic agents, and a number of liposomes have been approved for use in clinical
practice. After systemic administration, most liposomes are cleared by macrophages…